Markets:

Overview

News

Currencies

International

Treasuries

Accolade, Inc. - common stock (NQ:ACCD)

7.020 UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 7, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Accolade, Inc. - common stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Expert Ratings for Accolade ↗

November 22, 2023

Via Benzinga

Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday ↗

November 14, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azenta, Inc. (NASDAQ: AZTA) rose on Tuesday after the company reported better-than-expected fourth-quarter...

Via Benzinga

Topics Stocks

1 Market-Beating Stock to Buy Near Its 52-Week High ↗

October 19, 2023

This stock has been firing on all cylinders -- and it isn't about to stop.

Via The Motley Fool

Alignment Healthcare's Valuation Shows Promise In A Competitive Market: Analyst ↗

October 16, 2023

Alignment Healthcare Inc (NASDAQ: ALHC) announced that its California Medicare Advantage (MA) HMO – which represents roughly 89% of its MA membership – has maintained an overall 4 out of 5-star rating...

Via Benzinga

Why Shares of Accolade Fell This Week ↗

October 06, 2023

The company's fiscal 2024 second-quarter numbers showed improvement, but analysts and investors were not impressed.

Via The Motley Fool

Earnings Outlook For Accolade ↗

October 03, 2023

Via Benzinga

The Latest Analyst Ratings for Accolade ↗

August 14, 2023

Via Benzinga

Obesity Medication Insurance Coverage? Employers Embrace the Inclusion of Novo Nordisk's Wegovy in Health Coverage ↗

October 10, 2023

Coverage for obesity medications, including Novo Nordisk A/S's (NYSE: NVO) Wegovy, is expected to expand among U.S.

Via Benzinga

Why Eli Lilly Stock Crawled Higher Today ↗

October 09, 2023

The pharmaceutical giant gets a lift from some good news on insurance coverage and a prognosticator's price-target lift.

Via The Motley Fool

Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

October 05, 2023

Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent...

Via Benzinga

Raymond James Maintains Outperform Rating for Accolade: Here's What You Need To Know ↗

October 05, 2023

Via Benzinga

Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket ↗

October 05, 2023

Gainers

Via Benzinga

MaxCyte, Rivian Automotive And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

October 05, 2023

U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Conagra Brands, Constellation Brands And 3 Stocks To Watch Heading Into Thursday ↗

October 05, 2023

With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 04, 2023

Via Benzinga

Why Accolade Stock Is Falling After-Hours ↗

October 04, 2023

Accolade, Inc. (NASDAQ: ACCD) shares are trading lower after-hours on Wednesday after the company announced results for the second-quarter 2024

Via Benzinga

Accolade Announces Results for Fiscal Second Quarter 2024

October 04, 2023

From Accolade, Inc.

Via GlobeNewswire

Accolade Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

October 04, 2023

Accolade, Inc. (NASDAQ: ACCD) is expected to release financial results for its fiscal second quarter 2024 after the closing bell on Oct. 4, 2023.

Via Benzinga

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

September 01, 2023

The widely followed growth investor went stock shopping on the final trading day in August.

Via The Motley Fool

Cathie Wood Just Sold Nvidia -- and Bought These 5 Potentially Explosive Growth Stocks Again ↗

August 30, 2023

The famous growth investor has been making some interesting stock moves lately.

Via The Motley Fool

Cathie Wood's Bullish Stance on Flying Cars: Ark Buys $3.9M Worth of Archer Aviation Shares ↗

August 28, 2023

Via Benzinga

Cathie Wood's Ark Invest Adjusts Portfolio — Sells Nvidia Shares Worth Nearly $1.9M Amid AI Surge ↗

August 24, 2023

Via Benzinga

Topics Artificial Intelligence

Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks ↗

August 24, 2023

The Ark Invest CEO continues to trim Shopify holdings to fund some big purchases.

Via The Motley Fool

Every AI Stock Cathie Wood Owns, Ranked From Best to Worst ↗

August 12, 2023

You can find some great AI investment opportunities by looking at the stocks in Wood's Ark Invest portfolio.

Via The Motley Fool

Topics Artificial Intelligence

Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports ↗

August 07, 2023

Via Benzinga

Cathie Wood's Ark Invest Acquires $5.5M of Robinhood Shares Following Platform's First Profitable Quarter ↗

August 03, 2023

Via Benzinga

Cathie Wood Continues Iridium Shopping Spree — Ark Invest Buys $3.6M Worth Of Satellite Company's Stock ↗

August 02, 2023

Via Benzinga

Downgrade Aside, Cathie Wood Buys $1.2M Worth Of SoFi Shares ↗

July 27, 2023

Via Benzinga

Cathie Wood's Ark Invest Buys Spotify, Iridium Shares — Trims Tesla, Coinbase Holdings ↗

July 25, 2023

Via Benzinga

Cathie Wood's Ark Invest Makes Major Moves In This Warren Buffett-Backed EV Company, Moderna ↗

July 24, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.